Proconvulsant-induced seizures in α4 nicotinic acetylcholine receptor subunit knockout mice

Neuropharmacology

Volumn 43, Issue 1, 2002, Pages 55-64

  Wong, John Y F ^a   Ross, Shelley A ^a   McColl, Craig ^a   Massalas, Jim S ^a   Powney, Emma ^a   Finkelstein, David I ^a   Clark, Malcolm ^a   Horne, Malcolm K ^a   Berkovic, Samuel F ^b   Drago, John ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

4 nicotinic knockout; Bicuculline; Kainic acid; Pentylenetetrazole; Seizures; Strychnine

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 AMINOPYRIDINE; ALPHA4 NICOTINIC ACETYLCHOLINE RECEPTOR; BICUCULLINE; GLUTAMATE RECEPTOR AGONIST; GLYCINE RECEPTOR ANTAGONIST; KAINIC ACID; NICOTINIC RECEPTOR; PENTETRAZOLE; POTASSIUM CHANNEL BLOCKING AGENT; RECEPTOR SUBUNIT; STRYCHNINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; GENE DELETION; GENE MUTATION; KNOCKOUT MOUSE; MALE; MOUSE MUTANT; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; SEIZURE;

4-AMINOPYRIDINE; ANIMALS; BICUCULLINE; BINDING, COMPETITIVE; BRAIN; CONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; GABA ANTAGONISTS; GENOTYPE; KAINIC ACID; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PENTYLENETETRAZOLE; POTASSIUM CHANNEL BLOCKERS; RECEPTORS, GABA-A; RECEPTORS, NICOTINIC; SEIZURES; STRYCHNINE;

EID: 0036629924     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00067-9     Document Type: Article

References (39)

1. Akabas M.H., Kaufmann C., Archdeacon P., Karlin A. Identification of acetylcholine receptor channel-lining residues in the entire M2 segment of the alpha subunit. Neuron. 13:1994;919-927.
2. Alkondon M., Pereira E.F., Eisenberg H.M., Albuquerque E. X. Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks. Journal of Neuroscience. 20:2000;66-75.
3. A receptor dysfunction in epilepsy: a mutation in the γ2-subunit gene. Nature Genetics. 28:2001;46-48.
4. 3H]D-aspartate outflow in primary cultures of rat neocortical neurons: effect of acute and long term nicotine treatment. Neuropharmacology. 39:2000;2646-2653.
5. Ben-Ari Y., Cossart R. Kainate, a double agent that generates seizures: two decades of progress. Trends in Neurosciences. 23:2000;580-587.
6. Bertrand S., Weiland S., Berkovic S.F., Steinlein O.K., Bertrand D. Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy. British Journal of Pharmacology. 125:1998;751-760.
7. Brioni J.D., Decker M.W., Sullivan J.P., Arneric S.P. The pharmacology of (-)-nicotine and novel cholinergic channel modulators. Advances in Pharmacology. 37:1997;153-214.
8. Cramer C.L., Stagnitto M.L., Knowles M.A., Palmer G.C. Kainic acid and 4-aminopyridine seizure models in mice: evaluation of efficacy of anti-epileptic agents and calcium antagonists. Life Science. 54:1994;271-275.
9. Damaj M. I, Fei-Yin M., Dukat M., Glassco W., Glennon R.A., Martin B.R. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. Journal of Pharmacology and Experimental Therapeutics. 284:1998;1058-1065.
10. Drago J., Padungchaichot P., Accili D., Fuchs S. Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants. Developmental Neuroscience. 20:1998;188-203.
11. Elgoyhen A.B., Vetter D.E., Katz E., Rothlin C.V., Heinemann S.F., Boulter J. Alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proceedings of the National Academy of Sciences USA. 98:2001;3501-3506.
12. Ferraro T.N., Golden G.T., Smith G.G., St Jean P., Schork N.J., Mulholland N., Ballas C., Schill J., Buono R.J., Berrettini W.H. Mapping loci for pentylenetetrazole-induced seizure susceptibility in mice. Journal of Neuroscience. 19:1999;6733-6739.
13. Figl A., Viseshakul N., Shafaee N., Forsayeth J., Cohen B.N. Two mutations linked to nocturnal frontal lobe epilepsy cause use- dependent potentiation of the nicotinic ACh response. Journal Physiology. 513:1998;655-670.
14. Fusco M.D., Becchetti A., Patrignani A., Annesi G., Gambardella A., Quattrone A., Ballabio A., Wanke E., Casari G. The nicotinic receptor α2 subunit is mutant in nocturnal frontal lobe epilepsy. Nature Genetics. 26:2000;275-276.
15. Gioanni Y., Rougeot C., Clarke P.B., Lepouse C., Thierry A.M., Vidal C. Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamo-cortical transmission. European Journal of Neuroscience. 11:1999;18-30.
16. Hirose S., Iwata H., Akiyoshi H., Kobayashi K., Ito M., Wada K., Kaneko S., Mitsudome A. A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. Neurology. 53:1999;1749-1753.
17. Kayadjanian N., Retaux S., Menetrey A., Besson M.J. Stimulation by nicotine of the spontaneous release of [3H]gamma-aminobutyric acid in the substantia nigra and in the globus pallidus of the rat. Brain Research. 649:1994;129-135.
18. Kuryatov A., Gerzanich V., Nelson M., Olale F., Lindstrom J. Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors. Journal of Neuroscience. 17:1997;9035-9047.
19. Lena C., Changeux J.P., Mulle C. Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. Journal of Neuroscience. 13:1993;2680-2688.
20. Le Novere N., Changeaux J.P. Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells. Journal of Molecular Evolution. 40:1995;155-172.
21. Marubio L.M., del Mar Arroyo-Jimenez M., Cordero-Erausquin M., Lena C., Le Novere N., de Kerchove d'Exaerde A., Huchet M., Damaj M.I., Changeux J.P. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature. 398:1999;805-810.
22. Medina-Ceja L., Morales-Villagran A., Tapia R. Action of 4-aminopyridine on extracellular amino acids in hippocampus and entorhinal cortex: a dual microdialysis and electroencephalographic study in awake rats. Brain Research Bulletin. 53:2000;255-262.
23. Olsen R.W. The GABA postsynaptic membrane receptor-ionophore complex. Site of action of convulsant and anticonvulsant drugs. Molecular Cell Biochemistry. 39:1981;261-279.
24. Pena F., Tapia R. Seizures and neurodegeneration induced by 4-aminopyridine in rat hippocampus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels. Neuroscience. 101:2000;547-561.
25. Phillips H.A., Favre I., Kirkpatrick M., Zuberi S.M., Goudie D., Heron S.E., Scheffer I.E., Sutherland G.R., Berkovic S.F., Bertrand D., Mulley J.C. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. American Journal of Human Genetics. 68:2001;225-231.
26. Porter J.T., Cauli B., Tsuzuki K., Lambolez B., Rossier J., Audinat E. Selective excitation of subtypes of neocortical interneurons by nicotinic receptors. Journal of Neuroscience. 19:1999;5228-5235.
27. Ramanjaneyulu R., Ticku M.K. Interactions of pentamethylenetetrazole and tetrazole analogues with the picrotoxinin site of the benzodiazepine-GABA receptor-ionophore complex. European Journal of Pharmacology. 98:1984;337-345.
28. Role L.W., Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron. 16:1996;1077-1085.
29. Ross S.A., Wong J.Y.F., Clifford J.J., Kinsella A., Massalas J.S., Horne M.K., Scheffer I.E., Kola I., Waddington J.L., Berkovic S.F., Drago J. Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse. Journal of Neuroscience. 20:2000;6431-6441.
30. Ryan R., Ross S., Drago J., Loiacono R. Dose-related neuroprotective effects of chronic nicotine in 6- hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice. British Journal of Pharmacology. 132:2001;1650-1656.
31. Steinlein O.K., Mulley J.C., Propping P., Wallace R.H., Phillips H.A., Sutherland G.R., Scheffer I.E., Berkovic S.F. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nature Genetics. 11:1995;201-203.
32. Steinlein O.K., Magnusson A., Stoodt J., Bertrand S., Weiland S., Berkovic S.F., Nakken K.O., Propping P., Bertrand D. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Human Molecular Genetics. 6:1997;943-947.
33. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., Swanson L.W. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. Journal of Comparative Neurology. 284:1989;314-335.
34. Wallace R.H., Wang D.W., Singh R., Scheffer I.E., George A.L. Jr., Phillips H.A., Saar K., Reis A., Johnson E.W., Sutherland G.R., Berkovic S.F., Mulley J.C. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nature Genetics. 19:1998;366-370.
35. A receptor γ2-subunit in childhood absence epilepsy and febrile seizures. Nature Genetics. 28:2001;49-52.
36. Weiland S., Witzemann V., Villarroel A., Propping P., Steinlein O. An amino acid exchange in the second transmembrane segment of a neuronal nicotinic receptor causes partial epilepsy by altering its desensitization kinetics. FEBS Letters. 398:1996;91-96.
37. White H.S. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia. 40:1999;S2-S10.
38. Yamaguchi S., Rogawski M.A. Effects of anticonvulsant drugs on-aminopyridine-induced seizures in mice. Epilepsy Research 11. 4:1992;9-16.
39. Yang D.D., Kuan C.Y., Whitmarsh A.J., Rincon M., Zheng T.S., Davis R.J., Rakic P., Flavell R.A. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature. 389:1997;865-870.